HSKA - ヘスカ (Heska Corporation) ヘスカ

 HSKAのチャート


 HSKAの企業情報

symbol HSKA
会社名 Heska Corp. (ヘスカ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Biological Products (No Diagnostic Substances)  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 ヘスカ(Heska Corporation)は獣医向けの診断と特殊製品の販売に従事する会社。同社はコアコンパニオンアニマルヘルス(CCA)とその他のワクチン、医薬品と製品(OVP)事業という2つの事業セグメントを運営する。CCA事業セグメントは、主に犬と猫に使用される血液検査機器と消耗品、デジタル画像製品、ソフトウェアとサービス、ローカルとクラウドベースのデータサービス、アレルギー検査と免疫療法、並びに病院内診断テストとワーム予防製品などの単回使用製品を含む。OVP事業セグメントは、牛用、並びに馬、ブタ、鳥類、猫及び犬を含む他の種の動物向けの個人ラベルワクチンと薬品を含む。すべてのOVP製品はサードパーティのラベルの下で第三者によって販売される。同社は、犬や猫のヘルスケア分野における獣医師へのサポートを中心とする。同社は、獣医向けの血液検査と他の器具のラインを提供し、他の動物健康会社向けの生物学的製剤と医薬品を生産する。   ヘスカは米国の獣医製品メ―カ―。動物向けに医薬品ヘルスケア製品の開発、製造、販売、サポ―トを行う。犬・猫などのペット動物を対象に血液検査機器、フィラリア診断テスト、フィラリア予防製品、アレルギ―免疫療法製品、アレルギ―検査、およびデジタル画像製品を提供する。また、牛や小型哺乳類を含む他の動物向けにワクチンや医薬品を提供する。   Heska Corporation manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health.
本社所在地 3760 Rocky Mountain Avenue Loveland CO 80538 USA
代表者氏名 Sharon J. Larson シャロンJ.ラーソン
代表者役職名 Independent Chairman of the Board
電話番号 +1 970-493-7272
設立年月日 1988年
市場名 NASDAQ Small Cap
ipoyear 1997年
従業員数 345人
url www.heska.com
nasdaq_url https://www.nasdaq.com/symbol/hska
adr_tso
EBITDA EBITDA(百万ドル) 19.84200
終値(lastsale) 97.06
時価総額(marketcap) 727735594.46
時価総額 時価総額(百万ドル) 751.87850
売上高 売上高(百万ドル) 127.05000
企業価値(EV) 企業価値(EV)(百万ドル) 744.22250
当期純利益 当期純利益(百万ドル) 11.96300
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Heska Corp revenues decreased 1% to $62.4M. Net income decreased 49% to $4.1M. Revenues reflect Other Vaccines Pharmaceuticals_Products segment decrease of 32% to $9M. Net income also reflects Other Vaccines Pharmaceuticals_Products segment loss totaling $712K vs. income of $3.7M. Basic Earnings per Share excluding Extraordinary Items decreased from $1.13 to $0.57.

 HSKAのテクニカル分析


 HSKAのニュース

   Invesco V.I. Main Street Small Cap Fund Buys Heska Corp, The Honest Co Inc, Amyris Inc, Sells ...  2021/09/01 23:38:02 GuruFocus
Related Stocks: INSP , OLO , ADPT , CDMO , SATS , ONEM , HSKA , HNST , AMRS , NEU , FBK , BLI , EBS , PRSP , GTLS , NBLX , OSUR , IRTC ,
   Invesco Main Street Small Cap Fund Buys Heska Corp, The Honest Co Inc, Amyris Inc, Sells ...  2021/09/01 20:38:02 GuruFocus
Related Stocks: INSP , ADPT , OLO , QTWO , CDMO , SATS , HSKA , HNST , AMRS , NEU , FBK , BLI , ACCO , TNDM , EBS , PRSP , GTLS , OSUR , NBLX , IRTC ,
   Global Veterinary Diagnostics Market Report 2021-2028 Featuring Market Differentiators - Idexx Laboratories, Zoetis, Heska  2021/08/18 10:45:00 Business Insider Markets
DUBLIN, Aug. 18, 2021 /PRNewswire/ -- The
   Heska Corp (HSKA): Price Now Near $265.17; Daily Chart Shows An Uptrend on 20 Day Basis  2021/08/16 15:16:59 ETF Daily News
The moving averages on the daily timeframe suggest a bullishness in price, as the 20, 50, 100 and 200 are all in a bullish alignment -- meaning the shorter durations are above the longer duration averages, implying a sound upward trend. The post Heska Corp (HSKA): Price Now Near $265.17; Daily Chart Shows An Uptrend on 20 Day Basis appeared first on ETF Daily News .
   Heska Corp (HSKA) EVP, CFO Catherine Grassman Sold $1.3 million of Shares  2021/08/10 04:15:05 GuruFocus
Related Stocks: HSKA ,
   Heska Is Up More Than 70% in 6 Months -- Is It Too Late to Buy the Stock?  2021/04/01 10:25:00 The Motley Fool
Heska has benefited from fast growth in the veterinary market, but should investors keep betting on the stock?
   Veterinary Rapid Test Market Size 2027 – Global Industry Sales, Revenue, Price trends and more| IDEXX Laboratories, Inc., Zoetis, Inc., Virbac, Heska Corporation, Biopanda Reagents, Ltd., Fassisi GmbH, BioNote, Inc., SWISSAVANS AG  2021/03/15 16:36:08 OpenPR
Veterinary Rapid Test Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions across the world. Report provides is a professional inclusive study on the current state for the market. Analysis and
   Heska Announces Pricing of Upsized Public Offering of Common Stock  2021/03/03 03:00:00 PR Newswire
LOVELAND, Colo., March 2, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading provider of advanced veterinary diagnostic and specialty products, today announced the pricing of an underwritten public offering of 940,860 shares of its common…
   Heska Announces Proposed Public Offering of Common Stock  2021/03/01 21:05:00 PR Newswire
LOVELAND, Colo., March 1, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading provider of advanced veterinary diagnostic and specialty products, today announced that it has commenced an underwritten public offering of $150 million of shares of…
   Heska Corporation Reports Fourth Quarter and Full Year 2020 Results  2021/02/23 13:00:00 PR Newswire
LOVELAND, Colo., Feb. 23, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading provider of advanced veterinary diagnostic and specialty products, reported financial results in two segments (North America and International) for its fourth quarter and full…
   Heska Is Up More Than 70% in 6 Months -- Is It Too Late to Buy the Stock?  2021/04/01 10:25:00 The Motley Fool
Heska has benefited from fast growth in the veterinary market, but should investors keep betting on the stock?
   Veterinary Rapid Test Market Size 2027 – Global Industry Sales, Revenue, Price trends and more| IDEXX Laboratories, Inc., Zoetis, Inc., Virbac, Heska Corporation, Biopanda Reagents, Ltd., Fassisi GmbH, BioNote, Inc., SWISSAVANS AG  2021/03/15 16:36:08 OpenPR
Veterinary Rapid Test Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions across the world. Report provides is a professional inclusive study on the current state for the market. Analysis and
   Heska Announces Pricing of Upsized Public Offering of Common Stock  2021/03/03 03:00:00 PR Newswire
LOVELAND, Colo., March 2, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading provider of advanced veterinary diagnostic and specialty products, today announced the pricing of an underwritten public offering of 940,860 shares of its common…
   Heska Announces Proposed Public Offering of Common Stock  2021/03/01 21:05:00 PR Newswire
LOVELAND, Colo., March 1, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading provider of advanced veterinary diagnostic and specialty products, today announced that it has commenced an underwritten public offering of $150 million of shares of…
   Heska Corporation Reports Fourth Quarter and Full Year 2020 Results  2021/02/23 13:00:00 PR Newswire
LOVELAND, Colo., Feb. 23, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading provider of advanced veterinary diagnostic and specialty products, reported financial results in two segments (North America and International) for its fourth quarter and full…

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 ヘスカ HSKA Heska Corporation)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)